drugset / Trial / NCT02919644
Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.
Phase 2
Recruiting
19 enrolled
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
NaSingle-groupOpen-labelTreatment
Summary
Single-arm, monocentric trial to assess safety and immunological efficacy of adjuvant vaccination with autologous dendritic cells loaded with autologous tumour homogenate after curative resection for stage IV colorectal cancer
Timeline
- Start
- 2016-12-02
- Primary completion
- 2026-12
- Completion
- 2031-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous dendritic cells loaded with autologous tumour homogenate | Cell therapy | 1e+07 cells | Other |
| Background | aldesleukin | Protein / enzyme biologic | 3e+06 iu | Subcutaneous |